Cargando…
DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652460/ http://dx.doi.org/10.1186/2051-1426-3-S2-P427 |
| _version_ | 1782401758685822976 |
|---|---|
| author | Anastasopoulou, Eleftheria A Tzonis, Panagiotis Fortis, Sotirios P Mahaira, Louisa Vaxevanis, Christoforos Ardavanis, Alexandros Mittendorf, Elizabeth A Peoples, George E Baxevanis, Constantin N Papamichail, Michael Perez, Sonia A |
| author_facet | Anastasopoulou, Eleftheria A Tzonis, Panagiotis Fortis, Sotirios P Mahaira, Louisa Vaxevanis, Christoforos Ardavanis, Alexandros Mittendorf, Elizabeth A Peoples, George E Baxevanis, Constantin N Papamichail, Michael Perez, Sonia A |
| author_sort | Anastasopoulou, Eleftheria A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4652460 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46524602015-11-25 DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine Anastasopoulou, Eleftheria A Tzonis, Panagiotis Fortis, Sotirios P Mahaira, Louisa Vaxevanis, Christoforos Ardavanis, Alexandros Mittendorf, Elizabeth A Peoples, George E Baxevanis, Constantin N Papamichail, Michael Perez, Sonia A J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652460/ http://dx.doi.org/10.1186/2051-1426-3-S2-P427 Text en Copyright © 2015 Anastasopoulou et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Anastasopoulou, Eleftheria A Tzonis, Panagiotis Fortis, Sotirios P Mahaira, Louisa Vaxevanis, Christoforos Ardavanis, Alexandros Mittendorf, Elizabeth A Peoples, George E Baxevanis, Constantin N Papamichail, Michael Perez, Sonia A DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title | DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title_full | DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title_fullStr | DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title_full_unstemmed | DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title_short | DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine |
| title_sort | drb1*11 allele expression and her2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the her2 modified ae37 peptide vaccine |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652460/ http://dx.doi.org/10.1186/2051-1426-3-S2-P427 |
| work_keys_str_mv | AT anastasopouloueleftheriaa drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT tzonispanagiotis drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT fortissotiriosp drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT mahairalouisa drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT vaxevanischristoforos drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT ardavanisalexandros drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT mittendorfelizabetha drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT peoplesgeorgee drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT baxevanisconstantinn drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT papamichailmichael drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine AT perezsoniaa drb111alleleexpressionandher2preexistingimmunitymaypredictbenefitinbreastcancerpatientsvaccinatedwiththeher2modifiedae37peptidevaccine |